Clinical Lymphoma, Myeloma & Leukemia最新文献
英文
中文
OA-20 A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients
OA-20 基于循环肿瘤细胞的新预后系统，用于完善新诊断多发性骨髓瘤患者的分层状况
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01861-5
Ioannis Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Nikolaos Tsakirakis, Evangelos Eleftherakis-Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodaanthi-Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Meletios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
求助PDF
{"title":"OA-20 A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients","authors":"Ioannis Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Nikolaos Tsakirakis, Evangelos Eleftherakis-Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodaanthi-Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Meletios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos","doi":"10.1016/S2152-2650(24)01861-5","DOIUrl":"10.1016/S2152-2650(24)01861-5","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S13-S14"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-03 Talquetamab (tal) + Teclistamab (tec) in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Updated Phase 1B Results from RedirecTT-1 With >1 Year of Follow-Up
OA-03 Talquetamab (tal) + Teclistamab (tec) 用于复发性/难治性多发性骨髓瘤 (RRMM) 患者 (pts)：随访时间超过1年的RedirecTT-1最新1B期研究结果
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01844-5
Yaël Cohen, Hila Magen, Moshe Gatt, Michael Sebag, Kihyun Kim, Chang-Ki Min, Enrique Ocio, Sung-Soo Yoon, Michael Chu, Paula Rodríguez-Otero, Irit Avivi, Natalia Quijano Cardé, Maria Krevvata, Michelle Peterson, Emma Scott, Brandi Hilder, Jill Vanak, Arnob Banerjee, Albert Oriol, Daniel Morillo, María-Victoria Mateos Manteca
求助PDF
{"title":"OA-03 Talquetamab (tal) + Teclistamab (tec) in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Updated Phase 1B Results from RedirecTT-1 With >1 Year of Follow-Up","authors":"Yaël Cohen, Hila Magen, Moshe Gatt, Michael Sebag, Kihyun Kim, Chang-Ki Min, Enrique Ocio, Sung-Soo Yoon, Michael Chu, Paula Rodríguez-Otero, Irit Avivi, Natalia Quijano Cardé, Maria Krevvata, Michelle Peterson, Emma Scott, Brandi Hilder, Jill Vanak, Arnob Banerjee, Albert Oriol, Daniel Morillo, María-Victoria Mateos Manteca","doi":"10.1016/S2152-2650(24)01844-5","DOIUrl":"10.1016/S2152-2650(24)01844-5","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S2-S3"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
P-002 Ide-Cel Real-World (RW) and Clinical Trial Long-Term Safety Experience: A Special Focus on Movement and Neurocognitive Treatment Adverse Events (MNT AEs) and Second Primary Malignancies (SPMs)
P-002 Ide-Cel 真实世界 (RW) 和临床试验的长期安全性经验：特别关注运动和神经认知治疗不良事件（MNT AEs）和第二原发性恶性肿瘤（SPMs）
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01905-0
Rafat Abonour, Amani Kitali, Adrianna Gipson, Andrew Trovato, Marianne Shanker, Marissa Chiang, Arpitha Gunda, Soyun Park, Anna Truppel-Hartmann, Petra Schuberth, Paula Rodriguez-Otero
求助PDF
{"title":"P-002 Ide-Cel Real-World (RW) and Clinical Trial Long-Term Safety Experience: A Special Focus on Movement and Neurocognitive Treatment Adverse Events (MNT AEs) and Second Primary Malignancies (SPMs)","authors":"Rafat Abonour, Amani Kitali, Adrianna Gipson, Andrew Trovato, Marianne Shanker, Marissa Chiang, Arpitha Gunda, Soyun Park, Anna Truppel-Hartmann, Petra Schuberth, Paula Rodriguez-Otero","doi":"10.1016/S2152-2650(24)01905-0","DOIUrl":"10.1016/S2152-2650(24)01905-0","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S40-S41"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-33 LILRB4 Is a Promising Dual Target for Tumor Cells and Immunosuppressive Myeloid Cells in Multiple Myeloma
OA-33 LILRB4 是多发性骨髓瘤中肿瘤细胞和免疫抑制性髓系细胞的理想双靶点
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01874-3
Lixin Gong, Hao Sun, Jingyuan Ma, Xiyue Sun, Yijie Wang, An Gang, Xin Lin, Lugui Qiu, Mu Hao
求助PDF
{"title":"OA-33 LILRB4 Is a Promising Dual Target for Tumor Cells and Immunosuppressive Myeloid Cells in Multiple Myeloma","authors":"Lixin Gong, Hao Sun, Jingyuan Ma, Xiyue Sun, Yijie Wang, An Gang, Xin Lin, Lugui Qiu, Mu Hao","doi":"10.1016/S2152-2650(24)01874-3","DOIUrl":"10.1016/S2152-2650(24)01874-3","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S21-S22"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-48 Daratumumab (DARA)/Bortezomib/Lenalidomide/Dexamethasone (D-VRd) With D-R Maintenance (Maint) in Transplant-eligible (TE) Newly Diagnosed Myeloma (NDMM): PERSEUS Cytogenetic Risk Analysis
OA-48 Daratumumab (DARA)/Bortezomib/Lenalidomide/Dexamethasone (D-VRd) with D-R Maintenance (Maint) in Transplant-eligible (TE) Newly Diagnosed Myeloma (NDMM)：PERSEUS细胞遗传学风险分析
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01889-5
Meletios Dimopoulos, Pieter Sonneveld, Paula Rodríguez-Otero, Hang Quach, P. Joy Ho, Meral Beksac, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michele Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels van de Donk, Eirini Katodritou, Anna Sitthi-Amorn, Mario Boccadoro
求助PDF
{"title":"OA-48 Daratumumab (DARA)/Bortezomib/Lenalidomide/Dexamethasone (D-VRd) With D-R Maintenance (Maint) in Transplant-eligible (TE) Newly Diagnosed Myeloma (NDMM): PERSEUS Cytogenetic Risk Analysis","authors":"Meletios Dimopoulos, Pieter Sonneveld, Paula Rodríguez-Otero, Hang Quach, P. Joy Ho, Meral Beksac, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michele Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels van de Donk, Eirini Katodritou, Anna Sitthi-Amorn, Mario Boccadoro","doi":"10.1016/S2152-2650(24)01889-5","DOIUrl":"10.1016/S2152-2650(24)01889-5","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S30-S31"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
P-028 Characteristics of Bridging Therapy and Impact of Pre-lymphodepletion Tumor Burden on Clinical Outcomes of Idecabtagene Vicleucel
P-028 过渡疗法的特点以及淋巴消耗前肿瘤负担对Idecabtagene Vicleucel临床结果的影响
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01931-1
Doris Hansen, Omar Castaneda Puglianini, Brett Reid, Laura Oswald, Ariel Grajales-Cruz, Brandon Blue, Gabriel De Avila, Eric Smith, Salvatore Corallo, Hien Liu, Kenneth Shain, Rachid Baz, Taiga Nishihori, Melissa Alsina, David Huggar, Amani Kitali, Pallavi Patwardhan, Ciara Freeman, Frederick Locke, Simran Tiwana, Lauren Peres
求助PDF
{"title":"P-028 Characteristics of Bridging Therapy and Impact of Pre-lymphodepletion Tumor Burden on Clinical Outcomes of Idecabtagene Vicleucel","authors":"Doris Hansen, Omar Castaneda Puglianini, Brett Reid, Laura Oswald, Ariel Grajales-Cruz, Brandon Blue, Gabriel De Avila, Eric Smith, Salvatore Corallo, Hien Liu, Kenneth Shain, Rachid Baz, Taiga Nishihori, Melissa Alsina, David Huggar, Amani Kitali, Pallavi Patwardhan, Ciara Freeman, Frederick Locke, Simran Tiwana, Lauren Peres","doi":"10.1016/S2152-2650(24)01931-1","DOIUrl":"10.1016/S2152-2650(24)01931-1","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S56-S57"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-09 Mezigdomide Enhances Activity of BCMA-Targeted Cellular and T-Cell Engager Therapies and Mitigates Immune Toxicity in Preclinical Models of Multiple Myeloma
OA-09 麦吉多米德能增强多发性骨髓瘤临床前模型中 BCMA 靶向细胞疗法和 T 细胞诱导疗法的活性并减轻免疫毒性
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01850-0
Marta Larrayoz, Chad Chad Bjorklund, Maddalen Jimenez, Teresa Lozano, Sonia Sanz, Elena Arriazu, Rebecca Zon, Juan Roberto Rodríguez-Madoz, Bruno Paiva, Paula Rodríguez-Otero, Jesús San-Miguel, Felipe Prósper, Juan Jose Lasarte, Benjamin Ebert, Patrick Hagner, Jose Angel Martinez-Climent
求助PDF
{"title":"OA-09 Mezigdomide Enhances Activity of BCMA-Targeted Cellular and T-Cell Engager Therapies and Mitigates Immune Toxicity in Preclinical Models of Multiple Myeloma","authors":"Marta Larrayoz, Chad Chad Bjorklund, Maddalen Jimenez, Teresa Lozano, Sonia Sanz, Elena Arriazu, Rebecca Zon, Juan Roberto Rodríguez-Madoz, Bruno Paiva, Paula Rodríguez-Otero, Jesús San-Miguel, Felipe Prósper, Juan Jose Lasarte, Benjamin Ebert, Patrick Hagner, Jose Angel Martinez-Climent","doi":"10.1016/S2152-2650(24)01850-0","DOIUrl":"10.1016/S2152-2650(24)01850-0","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S6-S7"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-10 Impaired Membrane Trafficking of GPRC5D Mediates Resistance to Anti-GPRC5D TCE
OA-10 GPRC5D 的膜运输受损介导了对抗肿瘤药物 GPRC5D TCE 的耐药性
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01851-2
Holly Lee, Sungwoo Ahn, Noemie Leblay, Bachisio Ziccheddu, Marietta Truger, Michael Durante, Elie Barakat, Mansour Poorebrahim, David Jung, Ola Landgren, Hermann Einsele, K. Martin Kortüm, Jean Baptiste Alberge, Leo Rasche, Francesco Maura, Paola Neri, Nizar J. Bahlis
求助PDF
{"title":"OA-10 Impaired Membrane Trafficking of GPRC5D Mediates Resistance to Anti-GPRC5D TCE","authors":"Holly Lee, Sungwoo Ahn, Noemie Leblay, Bachisio Ziccheddu, Marietta Truger, Michael Durante, Elie Barakat, Mansour Poorebrahim, David Jung, Ola Landgren, Hermann Einsele, K. Martin Kortüm, Jean Baptiste Alberge, Leo Rasche, Francesco Maura, Paola Neri, Nizar J. Bahlis","doi":"10.1016/S2152-2650(24)01851-2","DOIUrl":"10.1016/S2152-2650(24)01851-2","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S7"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-22 A Single-Cell Atlas of Bone Marrow Immune Microenvironment Characterizes Dysregulation Associated With Multiple Myeloma Outcomes
OA-22 骨髓免疫微环境单细胞图谱描述了与多发性骨髓瘤结局相关的失调特征
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01863-9
Chaitanya Acharya, William Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova, Yered Pita-Juarez, Dimitra Karagkouni, Marina Michaud, Mark Hamilton, Shivani Nanda, Yizhe Song, Julia Wang, Sarthak Sathpathy, Yuling Ma, Jessica Schulman, Immune Network, Sagar Lonial, David Avigan, Swati Bhasin, Hearn Cho, Taxiarchis Kourelis, George Mulligan
求助PDF
{"title":"OA-22 A Single-Cell Atlas of Bone Marrow Immune Microenvironment Characterizes Dysregulation Associated With Multiple Myeloma Outcomes","authors":"Chaitanya Acharya, William Pilcher, Lijun Yao, Edgar Gonzalez-Kozlova, Yered Pita-Juarez, Dimitra Karagkouni, Marina Michaud, Mark Hamilton, Shivani Nanda, Yizhe Song, Julia Wang, Sarthak Sathpathy, Yuling Ma, Jessica Schulman, Immune Network, Sagar Lonial, David Avigan, Swati Bhasin, Hearn Cho, Taxiarchis Kourelis, George Mulligan","doi":"10.1016/S2152-2650(24)01863-9","DOIUrl":"10.1016/S2152-2650(24)01863-9","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S15"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
P-017 Impact of Genetic Ancestry on Outcomes and Toxicity of Ide-cel in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
P-017 遗传血统对复发性/难治性多发性骨髓瘤（RRMM）患者服用伊达凯（Ide-cel）治疗效果和毒性的影响
IF 2.7
4区 医学
Q2 HEMATOLOGY
Pub Date : 2024-09-01
DOI: 10.1016/S2152-2650(24)01920-7
Christen Dillard, Michelle Hildebrandt, Hans Lee, Nilesh Kalariya, Naveen Subramanian, Oren Pasvolsky, Christopher Ferreri, Mahmoud Gaballa, Sheeba Thomas, Donna Weber, Melody Becnel, Gregory Kaufman, Jessica Chen, Misha Hawkins, Michelly Abreu, Muzaffar Qazilbash, Robert Orlowski, Krina Patel
求助PDF
{"title":"P-017 Impact of Genetic Ancestry on Outcomes and Toxicity of Ide-cel in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)","authors":"Christen Dillard, Michelle Hildebrandt, Hans Lee, Nilesh Kalariya, Naveen Subramanian, Oren Pasvolsky, Christopher Ferreri, Mahmoud Gaballa, Sheeba Thomas, Donna Weber, Melody Becnel, Gregory Kaufman, Jessica Chen, Misha Hawkins, Michelly Abreu, Muzaffar Qazilbash, Robert Orlowski, Krina Patel","doi":"10.1016/S2152-2650(24)01920-7","DOIUrl":"10.1016/S2152-2650(24)01920-7","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S49-S50"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：